Literature DB >> 27325853

Reply to Yang et al and De Bari et al.

Daniel R Wahl1, Yebin Tao1, Matthew Schipper1, Theodore S Lawrence1, Mary Feng2.   

Abstract

Year:  2016        PMID： 27325853      PMCID： PMC5019762          DOI： 10.1200/JCO.2016.67.7492

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  7 in total

1.  Can Stereotactic Body Radiotherapy Really Be Considered the Preferred Treatment in Large Hepatocellular Carcinoma?

Authors:  Berardino De Bari; Mahmut Ozsahin; Pierre Bize; Tarek Boussaha; Gaël Deplanque; Dorothea Wagner; Jean Bourhis; Alban Denys
Journal:  J Clin Oncol       Date:  2016-06-20       Impact factor: 44.544

2.  Is Stereotactic Body Radiotherapy Better Than Radiofrequency Ablation for the Treatment of Hepatocellular Carcinoma?

Authors:  Jen-Fu Yang; Cheng-Hsiang Lo; Wen-Yen Huang
Journal:  J Clin Oncol       Date:  2016-06-20       Impact factor: 44.544

3.  Randomized Clinical Trial Comparing Proton Beam Radiation Therapy with Transarterial Chemoembolization for Hepatocellular Carcinoma: Results of an Interim Analysis.

Authors:  David A Bush; Jason C Smith; Jerry D Slater; Michael L Volk; Mark E Reeves; Jason Cheng; Roger Grove; Michael E de Vera
Journal:  Int J Radiat Oncol Biol Phys       Date:  2016-02-13       Impact factor: 7.038

4.  Sequential phase I and II trials of stereotactic body radiotherapy for locally advanced hepatocellular carcinoma.

Authors:  Alexis Bujold; Christine A Massey; John J Kim; James Brierley; Charles Cho; Rebecca K S Wong; Rob E Dinniwell; Zahra Kassam; Jolie Ringash; Bernard Cummings; Jenna Sykes; Morris Sherman; Jennifer J Knox; Laura A Dawson
Journal:  J Clin Oncol       Date:  2013-04-01       Impact factor: 44.544

5.  Stereotactic body radiation therapy in hepatocellular carcinoma and cirrhosis: evaluation of radiological and pathological response.

Authors:  Marcelo E Facciuto; Manoj K Singh; Caroline Rochon; Jyoti Sharma; Cecilia Gimenez; Umadevi Katta; Chitti R Moorthy; Stuart Bentley-Hibbert; Manuel Rodriguez-Davalos; David C Wolf
Journal:  J Surg Oncol       Date:  2011-09-29       Impact factor: 3.454

6.  Outcomes After Stereotactic Body Radiotherapy or Radiofrequency Ablation for Hepatocellular Carcinoma.

Authors:  Daniel R Wahl; Matthew H Stenmark; Yebin Tao; Erqi L Pollom; Elaine M Caoili; Theodore S Lawrence; Matthew J Schipper; Mary Feng
Journal:  J Clin Oncol       Date:  2015-11-30       Impact factor: 44.544

7.  Long-term outcomes of stereotactic body radiation therapy in the treatment of hepatocellular cancer as a bridge to transplantation.

Authors:  John K O'Connor; James Trotter; Gary L Davis; Jane Dempster; Goran B Klintmalm; Robert M Goldstein
Journal:  Liver Transpl       Date:  2012-08       Impact factor: 5.799
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.